Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
- Expanded laboratory capabilities support deeper mechanism-of-action research for stenoparib - New proteomics and cell line capabilities will broaden Allarity’s research capabilities to enable external partnerships